Pulse Biosciences is a development-stage medical device company using a novel and proprietary platform technology called Nano-Pulse Stimulation or NPS.
NPS is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue. We believe that NPS can induce a variety of cellular responses including secretion, apoptosis and necrosis by modulating the NPS pulses, making it applicable to a wide variety of cell types and therapeutic applications. One of the more promising applications of NPS is the treatment of solid tumors, where pre-clinical data have shown that NPS provides effective local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. We believe we will establish NPS as a new treatment modality across a variety of applications, including oncology, dermatology, and other minimally invasive applications where current ablation modalities do not provide the benefits of NPS.